VisionPoint Advisory Group’s iShares Biotechnology ETF IBB Stock Holding History

VisionPoint Advisory Group’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,292	Closed	-$1.87M	–	800
2023 Q3	$1.87M	Sell	15,292 -1,398	-8%	-$178K	0.8%	32
2023 Q2	$2.12M	Buy	16,690 +2,026	+14%	+$263K	0.87%	29
2023 Q1	$1.91M	Buy	+14,664	New	+$1.92M	0.84%	32
2022 Q1	–	Sell	-1,568	Closed	-$205K	–	96
2021 Q4	$205K	Sell	1,568 -148	-9%	-$22.9K	0.09%	97
2021 Q3	$269K	Hold	1,716	–	–	0.12%	88
2021 Q2	$281K	Sell	1,716 -17,950	-91%	-$2.76M	0.13%	85
2021 Q1	$2.96M	Buy	19,666 +6,853	+53%	+$1.09M	1.42%	20
2020 Q4	$1.94M	Buy	12,813 +7,195	+128%	+$1.03M	0.98%	27
2020 Q3	$761K	Buy	5,618 +1,460	+35%	+$198K	0.33%	43
2020 Q2	$567K	Buy	4,158 +558	+16%	+$71.1K	0.23%	49
2020 Q1	$388K	Buy	+3,600	New	+$414K	0.18%	68

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

VisionPoint Advisory Group's IBB Position: Q4 2023 in Review

VisionPoint Advisory Group sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 15,292 shares — an estimated $1.87M sold.

VisionPoint Advisory Group first reported a position in IBB in Q1 2020 and held it in 11 quarters. The position peaked at $2.96M in Q1 2021. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

VisionPoint Advisory Group reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
VisionPoint Advisory Group sold 15,292 iShares Biotechnology ETF shares in Q4 2023, an estimated $1.87M.
VisionPoint Advisory Group first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 11 quarters.
VisionPoint Advisory Group's iShares Biotechnology ETF position peaked at $2.96M in Q1 2021.
872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on VisionPoint Advisory Group's 13F filing for Q4 2023, filed 7 Feb 2024.